Kaiser Permanente Southern California to lead CDC-funded center to improve outbreak and disease prediction
Kaiser Permanente Southern California has been tapped to lead an innovation center that will develop advanced modeling approaches to better predict disease outbreaks and prepare the United States for future public health emergencies. The center is 1 of 13 sites that will form the Outbreak Analytics ...
Featured News
Diabetes increased among kids during pandemic
A study of more than 1 million Kaiser Permanente members ages 19 and younger found that rates of both type 1 and type 2 diabetes increased among children during the COVID-19 pandemic, particularly for ...
Kaiser Permanente cancer survival rates higher
Kaiser Permanente had better 5-year survival rates among breast, colorectal, and lung cancer patients compared to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) ...
Five questions for … Dr. Titilola Labisi
Titilola Labisi, PhD, MHA, MPH, is a public health researcher and a postdoctoral research fellow in the Division of Behavioral Research of the Department of Research & Evaluation. She joined the ...
New Virtual Research Office enables physician research
December 14, 2021Kaiser Permanente Southern California has launched a new Virtual Research Office portal to make it easier for physicians to conduct clinical research that can have a direct impact on the quality of care provided to Kaiser Permanente members. The new portal, developed and housed by the Department of Research & Evaluation, provides a single point of ...Read more...People with HIV are at increased risk for heart failure
December 13, 2021People with HIV are at higher risk of developing heart failure than people without HIV, a new study found. The research, published Dec. 13, 2021, in Mayo Clinic Proceedings, is one of the largest studies to investigate heart failure risk in people with HIV and how that risk varies by age, gender, race, and ethnicity. “Cardiovascular ...Read more...Moderna COVID-19 vaccine is effective 5 months after 2nd dose
November 29, 2021Kaiser Permanente research in Southern California published November 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the second dose. Effectiveness was 87% against COVID-19 infection, 96% against COVID-19 hospitalization, and 98% against COVID-19 death. “This research provides reassuring evidence of the high effectiveness of ...Read more...Higher risk of dementia for older adults living with HIV
November 28, 2021A study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The rate of dementia decreased over time for both groups but remained higher for those with HIV, reported research published in the journal AIDS. The study compared more than 13,000 people with HIV, ages ...Read more...Exercise during pandemic linked to better mental health
November 10, 2021People who exercised more during the initial lockdown period of the COVID-19 pandemic experienced less anxiety and depression than those who didn’t exercise, according to new research published November 11, 2021, in Preventive Medicine. The research also showed that people who spent more time outdoors typically experienced lower levels of anxiety and depression than those ...Read more...Five questions for … Dr. Stanley Xu
November 10, 2021Dr. Stanley Xu is a senior research scientist biostatistician in the Division of Biostatistics Research in the Department of Research & Evaluation. He has served as principal investigator, co-investigator, and lead biostatistician on randomized trials and observational studies funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Centers for Disease Control ...Read more...Kaiser Permanente members invited to join flu vaccine study
October 27, 2021The Centers for Disease Control and Prevention has selected Kaiser Permanente Southern California as a new site in its U.S. Flu Vaccine Effectiveness network. Kaiser Permanente Southern California is inviting its members to participate in a nationwide study of how well flu and COVID-19 vaccines are working. It is one of 2 new sites selected by ...Read more...New study looking at millions of vaccinated and unvaccinated people found no increased risk of death among COVID-19 vaccine recipients
October 22, 2021COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren’t vaccinated, according to Kaiser Permanente research published Oct. 22, 2021 in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report. “Despite numerous studies showing the safety of COVID-19 vaccines, some people have remained hesitant to get vaccinated,” said lead author Stanley ...Read more...Kaiser Permanente study to assess COVID-19 antibodies in employees, physicians
October 22, 2021A physician investigator in the Southern California Permanente Medical Group received a grant to study antibody responses to COVID-19 vaccination among health care workers. The study will also help learn more about the impact of booster vaccination and the rates of asymptomatic COVID-19 infection among the vaccinated. Kaiser Permanente Southern California is inviting up to 2,000 ...Read more...Five questions for … Dr. Debbie Malden
October 19, 2021Debbie Malden, DPhil, MSc, is an epidemiologist with research experience in large-scale prospective cohort studies. Before joining Kaiser Permanente, Dr. Malden completed her DPhil at the University of Oxford, assessing risk factors for cardiovascular disease among a half million U.K. adults using both observational and genetic epidemiological techniques. In addition to her research on chronic disease, ...Read more...